Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s affordable medicines — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s affordable medicines — goodwill?
- Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — goodwill of $158.02M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s affordable medicines — goodwill changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s affordable medicines — goodwill decreased by 2.3% year-over-year, from $161.72M to $158.02M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s affordable medicines — goodwill?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s affordable medicines — goodwill has grown at a 6.4% compound annual growth rate (CAGR), from $501.6M to $643.21M.
- What does affordable medicines — goodwill mean?
- Reflects the intangible asset value recorded when the purchase price of an acquired business within the Affordable Medicines segment exceeds the fair value of its identifiable net assets. It represents the premium paid for brand reputation, customer relationships, and future synergies expected from the acquisition.